RPL31
Large ribosomal subunit protein eL31
Also known as: L31, RL31_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62899
- Gene
- RPL31
- Ensembl
- ENSG00000071082
- Chromosome
- 2
- Canonical length
- 125 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Ribosomal proteins
OverviewNCBI Gene
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L31E family of ribosomal proteins. It is located in the cytoplasm. Higher levels of expression of this gene in familial adenomatous polyps compared to matched normal tissues have been observed. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
125 residues, UniProt reviewed canonical sequence.
>P62899|RPL31
1 MAPAKKGGEK KKGRSAINEV VTREYTINIH KRIHGVGFKK RAPRALKEIR KFAMKEMGTP
61 DVRIDTRLNK AVWAKGIRNV PYRIRVRLSR KRNEDEDSPN KLYTLVTYVP VTTFKNLQTV
121 NVDENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL31 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 5,785 nTPM
Expression across tissuesHPA
Tissue
- ovary: 5,785 nTPM
- bone marrow: 4,006 nTPM
- pancreas: 3,499 nTPM
- cervix: 3,234 nTPM
- skin: 3,109 nTPM
- amygdala: 3,062 nTPM
Single-cell type
- decidual stromal cells: 7,456 nCPM
- ovarian stromal cells: 6,950 nCPM
- esophageal suprabasal cells: 6,393 nCPM
- esophageal apical cells: 5,696 nCPM
- extravillous trophoblasts: 5,671 nCPM
- epididymal efferent duct absorptive cells: 5,581 nCPM
Immune cell
- total PBMC: 14,498 nTPM
- naive CD4 T-cell: 10,671 nTPM
- naive CD8 T-cell: 8,809 nTPM
- memory B-cell: 8,507 nTPM
- memory CD4 T-cell: 7,832 nTPM
- MAIT T-cell: 7,250 nTPM
Brain region
- thalamus: 683 nTPM
- spinal cord: 642 nTPM
- white matter: 617 nTPM
- basal ganglia: 607 nTPM
- cerebral cortex: 584 nTPM
- amygdala: 578 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RPL31.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 79 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 1.64
- DepMap mean gene effect
- -2.54
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Large ribosomal subunit protein eL31
- Large ribosomal subunit protein eL31, conserved site
- Large ribosomal subunit protein eL31 domain superfamily
- Ribosomal protein L31e
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPL31 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL31 as an antibody target. Whether an autoantibody or antibody against RPL31 could matter depends on whether native RPL31 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL31 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL31 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...